549 related articles for article (PubMed ID: 15558805)
1. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
[TBL] [Abstract][Full Text] [Related]
2. Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma.
Hartmann JT; Meisinger I; Kröber SM; Weisel K; Klingel K; Kanz L
Haematologica; 2006 Dec; 91(12 Suppl):ECR49. PubMed ID: 17194655
[TBL] [Abstract][Full Text] [Related]
3. Dose-by-dose virological and hematological responses to intravenous immunoglobulin in an immunocompromised patient with persistent parvovirus B19 infection.
Tang JW; Lau JS; Wong SY; Cheung JL; Chan CH; Wong KF; Wong A; Chan PK
J Med Virol; 2007 Sep; 79(9):1401-5. PubMed ID: 17607784
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19 infection after plasma exchange for myasthenia gravis.
Bianchi M; Rago I; Zini G; D'Onofrio G; Leone G
Lab Hematol; 2007; 13(1):34-8. PubMed ID: 17353182
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.
Wong TY; Chan PK; Leung CB; Szeto CC; Tam JS; Li PK
Am J Kidney Dis; 1999 Dec; 34(6):1132-6. PubMed ID: 10585325
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of Pure Red Cell Aplasia in a Kidney Transplant Recipient Due to Reactivation of Parvovirus B19 Infection Despite Two Cycles of Intravenous Immunoglobulin Therapy.
Kaya B; Paydas S
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):195-197. PubMed ID: 30777553
[TBL] [Abstract][Full Text] [Related]
7. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.
Tavil B; Sanal O; Turul T; Yel L; Gurgey A; Gumruk F
Pediatr Hematol Oncol; 2009 Mar; 26(2):63-8. PubMed ID: 19322736
[TBL] [Abstract][Full Text] [Related]
9. [Congenital aplastic anemia caused by parvovirus B19 infection].
Vepreková L; Jelínek J; Zeman J
Cas Lek Cesk; 2001 Mar; 140(6):178-80. PubMed ID: 11347208
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia.
Mouthon L; Guillevin L; Tellier Z
Autoimmun Rev; 2005 Jun; 4(5):264-9. PubMed ID: 15990072
[TBL] [Abstract][Full Text] [Related]
12. Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient.
Bergen GA; Sakalosky PE; Sinnott JT
J Heart Lung Transplant; 1996 Aug; 15(8):843-5. PubMed ID: 8878766
[TBL] [Abstract][Full Text] [Related]
13. [Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report].
Banno S; Matsumoto Y; Sugiura Y; Ueda R
Ryumachi; 1997 Aug; 37(4):581-6. PubMed ID: 9311285
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus B19 infection presenting as pre-B-cell acute lymphoblastic leukemia: a transient and progressive course in two children.
Yetgin S; Cetin M; Aslan D; Ozyurek E; Anlar B; Uçkan D
J Pediatr Hematol Oncol; 2004 Oct; 26(10):689-92. PubMed ID: 15454845
[TBL] [Abstract][Full Text] [Related]
15. Long-term remission of recurrent parvovirus-B associated anemia in a renal transplant recipient induced by treatment with immunoglobulin and positive seroconversion.
Kumar J; Shaver MJ; Abul-Ezz S
Transpl Infect Dis; 2005 Mar; 7(1):30-3. PubMed ID: 15984946
[TBL] [Abstract][Full Text] [Related]
16. [Parvovirus B19-induced pure red cell aplasia in a liver transplant recipient].
Lee EY; Cho Y; Lee SG; Song J
Korean J Lab Med; 2010 Dec; 30(6):591-4. PubMed ID: 21157144
[TBL] [Abstract][Full Text] [Related]
17. Parvovirus B19 infection presenting with severe erythroid aplastic crisis during pregnancy in a woman with autoimmune hemolytic anemia and alpha-thalassemia trait: a case report.
Chen CC; Chen CS; Wang WY; Ma JS; Shu HF; Fan FS
J Med Case Rep; 2015 Mar; 9():58. PubMed ID: 25889935
[TBL] [Abstract][Full Text] [Related]
18. Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation.
Wasak-Szulkowska E; Grabarczyk P; Rzepecki P
Transpl Infect Dis; 2008 Jun; 10(3):201-5. PubMed ID: 17631000
[TBL] [Abstract][Full Text] [Related]
19. Aplastic anemia successfully treated with rituximab.
Hansen PB; Lauritzen AM
Am J Hematol; 2005 Dec; 80(4):292-4. PubMed ID: 16315256
[TBL] [Abstract][Full Text] [Related]
20. Chronic parvovirus B19 infection leading to red cell aplasia following treatment of Hodgkin lymphoma.
Poplar S; Allford S; Rooney N
Br J Haematol; 2010 Mar; 148(5):671. PubMed ID: 19681883
[No Abstract] [Full Text] [Related]
[Next] [New Search]
